FADDA, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 209.066
NA - Nord America 13.318
AS - Asia 6.320
SA - Sud America 1.007
AF - Africa 185
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 14
Totale 229.929
Nazione #
IT - Italia 200.377
US - Stati Uniti d'America 13.058
NL - Olanda 5.111
SG - Singapore 2.471
CN - Cina 2.130
UA - Ucraina 823
SE - Svezia 805
BR - Brasile 795
DE - Germania 507
VN - Vietnam 502
FI - Finlandia 443
GB - Regno Unito 390
FR - Francia 295
IN - India 205
HK - Hong Kong 194
KR - Corea 148
CA - Canada 129
BD - Bangladesh 109
TR - Turchia 89
IQ - Iraq 70
AR - Argentina 69
MX - Messico 66
RU - Federazione Russa 50
JP - Giappone 49
ES - Italia 46
SA - Arabia Saudita 41
EC - Ecuador 40
ZA - Sudafrica 38
PL - Polonia 37
PK - Pakistan 36
MA - Marocco 34
UZ - Uzbekistan 32
AT - Austria 29
VE - Venezuela 29
BE - Belgio 27
ID - Indonesia 27
PH - Filippine 27
CO - Colombia 25
NP - Nepal 22
CZ - Repubblica Ceca 21
JO - Giordania 21
KE - Kenya 21
IE - Irlanda 19
IR - Iran 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
EG - Egitto 16
CL - Cile 15
MY - Malesia 15
ET - Etiopia 14
IL - Israele 14
JM - Giamaica 13
BO - Bolivia 12
EU - Europa 12
CH - Svizzera 11
LB - Libano 11
AZ - Azerbaigian 10
DZ - Algeria 10
PA - Panama 10
TN - Tunisia 10
GR - Grecia 9
PY - Paraguay 9
RS - Serbia 9
DO - Repubblica Dominicana 8
LT - Lituania 8
CR - Costa Rica 7
HU - Ungheria 7
OM - Oman 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
GE - Georgia 6
KZ - Kazakistan 6
NG - Nigeria 6
PT - Portogallo 6
SN - Senegal 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
HR - Croazia 5
PE - Perù 5
UY - Uruguay 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
KG - Kirghizistan 4
PR - Porto Rico 4
RO - Romania 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
KH - Cambogia 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
AL - Albania 2
BH - Bahrain 2
BS - Bahamas 2
Totale 229.877
Città #
Cagliari 194.823
Amsterdam 5.050
Uta 4.633
Singapore 1.210
Ashburn 1.171
Fairfield 1.057
Chandler 870
Woodbridge 841
San Jose 797
Ann Arbor 683
Dallas 665
Houston 606
Boardman 553
Jacksonville 446
Nyköping 443
Seattle 443
Wilmington 408
Cambridge 357
Beijing 341
Dearborn 290
Helsinki 269
Los Angeles 256
Council Bluffs 228
Hefei 193
New York 188
Hong Kong 176
Shanghai 174
Nanjing 167
Lauterbourg 161
Santa Clara 158
The Dalles 154
Boston 143
Seoul 138
Ho Chi Minh City 130
Hanoi 116
Milan 98
Buffalo 80
Munich 80
São Paulo 67
San Diego 64
Shenyang 64
Guangzhou 62
Dong Ket 61
Rome 61
Orem 55
Frankfurt am Main 54
Chennai 53
London 53
Redwood City 53
Toronto 49
Tianjin 48
Chicago 44
Nanchang 43
Redondo Beach 42
Mountain View 41
Washington 41
Sassari 39
Atlanta 38
Denver 38
Tokyo 38
Brooklyn 34
Jiaxing 34
Verona 34
Turku 33
Hebei 31
Kocaeli 30
Manchester 30
Tashkent 29
Changsha 28
Norwalk 28
Pune 28
Baghdad 27
Columbus 27
Warsaw 27
Brussels 26
Montreal 26
Nuremberg 26
Paris 26
Wuhan 25
Madrid 22
Orange 22
Mumbai 21
San Francisco 21
Belo Horizonte 20
Brasília 20
Da Nang 20
Kunming 20
Phoenix 20
Poplar 20
Rio de Janeiro 20
Johannesburg 19
Mexico City 19
Nairobi 19
Ningbo 19
Amman 18
Dhaka 18
Jinan 18
Zhengzhou 18
Casablanca 17
Dublin 17
Totale 220.661
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.675
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.636
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function 4.489
Maternal immune activation disrupts dopamine system in the offspring 4.152
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.904
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.382
BEHAVIORAL EFFECTS OF ACUTE ADMINISTRATION OF THE PPAR-α AGONIST PALMITOYLETHANOLAMIDE IN RATS 3.371
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.358
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.345
Emotional profile of female rats showing binge eating behavior 3.261
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.234
Sex differences in addictive disorders 3.182
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats 3.172
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.095
Acute administration of palmitoylethanolamide: behavioural studies 2.980
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.971
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.963
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.900
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.880
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.850
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.824
Antidepressant-like effect of clofibrate: a synthetic PPAR-a agonist 2.771
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.722
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.600
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.598
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission 2.584
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings 2.516
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.513
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.480
Piano di uguaglianza di genere dell’Università degli Studi di Cagliari 2.454
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.399
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.389
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 2.385
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.355
Brain activity of anandamide: a rewarding bliss? 2.280
Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview 2.271
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.232
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.231
Increased cannabinoid intravenous self-administration in the olfactory bulbectomy rats model of depression 2.215
Methoxetamine affects brain processing involved in emotional response in rats 2.188
Animal Models of Eating Disorders 2.168
Analysis of opioid-seeking reinstatement in the rat 2.143
The GABA(B) receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats 2.100
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.022
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo (3.2.1) octanes 1.980
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.958
null 1.948
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats. 1.896
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.883
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.869
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.767
Sex differences in the self-administration of cannabinoids and other drugs of abuse 1.745
THC exposure during adolescence increases cannabinoid and heroin intake in female rats more than in males 1.725
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.680
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats 1.664
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.633
null 1.579
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.506
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.488
Effects of modulation of endocannabinoid system on fat intake under a limited-access protocol of binge eating in female rats 1.460
The endocannabinoid system and nondrug rewarding behaviours 1.458
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.450
Hippocampal theta activity is modulated by cannabinoid type1receptor in rats 1.416
Drug and cue induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones 1.402
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.369
Neurobiological mechanisms of cannabinoid addiction 1.291
Cannabinoids and their therapeutic applications in mental disorders 1.274
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.254
Differential effects of THC-or CBD-rich cannabis extracts on working memory in rats 1.225
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.161
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.146
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.077
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.063
Cannabinoid-opioid interaction in relapse to drug-seeking 1.060
Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone 1.060
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.058
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.037
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.030
Endocannabinoid system and opioid addiction: behavioural aspects 1.018
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs 1.014
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 979
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 960
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives 955
Analysis of opioid-seeking behavior through the intravenous self-administration reinstatement model in rats 951
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 946
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 942
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 866
Reduction of Corticostriatal Glutamatergic Fibers in Basic Fibroblast Growth Factor Deficient Mice is Associated with Hyperactivity and Enhanced Dopaminergic Transmission 864
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 817
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. 801
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 777
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 774
Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil 772
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 765
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 752
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 740
null 738
SYNTHETIC AND PLANT-DERIVED CANNABINOID RECEPTOR ANTAGONISTS SHOW HYPOPHAGIC PROPERTIES IN FASTED AND NON-FASTED MICE 722
null 711
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 698
Totale 196.414
Categoria #
all - tutte 300.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 300.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.703 0 0 0 0 0 0 0 0 0 0 0 1.703
2021/202211.694 1.483 831 462 1.043 1.262 804 613 627 1.023 1.282 1.239 1.025
2022/202317.564 1.499 2.292 2.442 1.486 1.397 1.700 815 1.319 1.127 1.154 1.575 758
2023/202417.789 903 649 829 1.222 1.746 3.337 2.416 1.109 990 1.311 1.598 1.679
2024/202539.679 8.541 8.982 5.311 4.107 1.965 2.205 3.168 299 514 3.551 438 598
2025/202614.154 1.172 700 1.353 1.220 975 975 2.012 511 2.710 1.421 818 287
Totale 230.502